HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Six hundred endometrial laser ablations.

AbstractOBJECTIVE:
To report the effectiveness and safety of endometrial laser ablation in the treatment of menorrhagia, as determined by detailed follow-up of 600 operations for at least 6 months.
METHODS:
Operative data from 600 endometrial laser ablations performed on 524 women were collected. Five hundred one (96%) of these women were followed with consultations and questionnaires. The mean duration of follow-up was 15 months (range 6-42).
RESULTS:
No major operative morbidity occurred. There were no cases of primary or secondary hemorrhage, uterine perforations with the operating instrument, or immediate laparotomy. A successful outcome was reported by 83.4% of patients. A second endometrial laser ablation was required in 14.3% of the women. Success increased with increasing age and low fluid absorption. Cavity length, operation time, duration of follow-up, and whether it was a first or second procedure were not associated with any difference in the success rate, although the hysterectomy rate tended to rise with increasing length of follow-up.
CONCLUSION:
This study, the largest one published from a single institution, with a mean follow-up duration of 15 months, confirms that endometrial laser ablation is a safe and effective treatment for dysfunctional uterine bleeding.
AuthorsR Garry, D Shelley-Jones, P Mooney, G Phillips
JournalObstetrics and gynecology (Obstet Gynecol) Vol. 85 Issue 1 Pg. 24-9 (Jan 1995) ISSN: 0029-7844 [Print] United States
PMID7800318 (Publication Type: Clinical Trial, Journal Article)
Chemical References
  • Furosemide
Topics
  • Absorption
  • Adult
  • Age Factors
  • Amenorrhea (epidemiology, etiology)
  • Body Fluids (metabolism)
  • Catheter Ablation
  • Endometrium (surgery)
  • Female
  • Follow-Up Studies
  • Furosemide (administration & dosage)
  • Humans
  • Hysterectomy
  • Intraoperative Care
  • Laser Therapy (adverse effects, methods)
  • Menorrhagia (etiology, metabolism, surgery)
  • Middle Aged
  • Postoperative Complications (epidemiology, etiology)
  • Regression Analysis
  • Reoperation
  • Retrospective Studies
  • Time Factors
  • Treatment Outcome

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: